Chemogenetic tools such as designer receptors exclusively activated by designer drugs (DREADDs) are routinely used to modulate neuronal and non-neuronal signaling and activity in a relatively noninvas
Odds ratio of ACE I/D and all-cause CKD, diabetic nephropathy, non-diabetic nephropathy using assumption of allele type, genotype, dominant and recessive model.
Background: Chronic kidney disease (CKD) is a public health issue, and an independent risk factor for cardiovascular disease. The peroxisome proliferator-activated receptor gamma (PPARG) plays an impo
